- How is the UK performing against European peers on life sciences metrics? Presentation as part of the Knowledge Group webinar, "Brexit's Promises and Problems: Mapping out new strategy for life sciences industry" 23 Feb 2016
- Myeloma UK, Access to medicines in Scotland event 21 Apr 2016 t
- Pay-for-performance and drug pricing: Impact and response of pharma, FirstWord ExpertViews Dossier Report, Mar 2016
- Lexington Communications, What does the future look like for market access in England? 25 Feb 2016 See the write up here t
- Breast Cancer Now, Access to medicines summit 26 Jan 2016
- Britain Against Cancer 2015, Panel member on Unlocking drugs: How do we get treatments to those who need them? 8 Dec 2015 See a pic of the panel here
- Market Access Value Studies: Developing effective message and communications with payers, FirstWord ExpertViews Dossier Report, Nov 2015
- Britain Against Cancer 2014, Panel member on Access to Medicines debate, London, 9 Dec 2014
- Empower Access to Medicines Campaign Meeting at Westminster, London, 21 Jan 2014 mentioned in Empower Access to Medicines blog here
- Interserve Roundtable, A journey for patients: effective commissioning and integration of healthcare, 28th Nov 2013
- Cancer52 Viewpoints on VBP and CDF: 60 second interviews with Eric Low, Dave Ryner and Leela Barham Sept 2013
- Department of Health, Expert Workshop on Equalities Impact of Value Based Pricing, 4 Feb 2013 for Cancer52
- Department of Health, Expert Workshop on Wider Societal Benefits in Value Based Pricing, 24 Oct 2012 for Cancer52
- The Current Health Technology Appraisal Landscape and its Impact on Access to Medicines for Rare Diseases, Contribution to Celgene Debate: The Implementation of the Health and Social Care Act will Improve Patient Access to Medicines and Reduce Healthcare Inequalities for People with Rarer Conditions: Do You Agree? 10 Jul 2012, London
- Making Work Count: How Health Technology Assessment Can Keep Europeans in Work Fit for Work European Coalition 2012
- Pricing and Reimbursement Trends in the US: Impact of Comparative Effectiveness Research and Cost Effectiveness Analysis FirstWord Jan 2012
- Adding Value: The Economic and Societal Benefits of Medical Technology The Work Foundation Nov 2011
- Expert Panel: Navigate the Global Regulatory Framework for Successful Market Access, CBI Global Pricing and Market Access Strategies, 21 Jan 2010 Philadelphia t
Journalists
- Sarah Bosely, The Guardian
- Phil Kemp, File on 4 on Radio 4
- Mike Fox, The One Show
- Rebecca Maxted, BBC Radio 4
For transparency, those activities with £ are activities for which I received payment and t are activities for which I did not receive payment but where my travel expenses (at standard class) were reimbursed. Where there is no symbol, I received no payment for the activity and self-funded my travel expenses, if applicable.
